Litigation Settlement, Number Of Installments

No definition available.

Name:	mygn_LitigationSettlementNumberOfInstallments
Namespace Prefix:	mygn_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Amount awarded to other party in judgment or settlement of litigation.

+ References

No definition available.

+ Details

Name:	us-gaap_LitigationSettlementAmountAwardedToOtherParty
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 460
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482425/460-10-50-3

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483076/450-20-50-1

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483076/450-20-50-4

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483076/450-20-50-4

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483076/450-20-50-9

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483076/450-20-50-9

+ Details

Name:	us-gaap_LossContingenciesLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of loss contingency liability.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483076/450-20-50-1

Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 10
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483076/450-20-50-10

+ Details

Name:	us-gaap_LossContingencyAccrualAtCarryingValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer.

+ References

+ Details

Name:	us-gaap_LossContingencyAccrualCarryingValueCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of loss contingency liability expected to be resolved after one year or beyond the normal operating cycle, if longer.

+ References

+ Details

Name:	us-gaap_LossContingencyAccrualCarryingValueNoncurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Number of another entity's patents that the entity has allegedly infringed.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483076/450-20-50-4

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 450
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 9
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483076/450-20-50-9

+ Details

Name:	us-gaap_LossContingencyPatentsAllegedlyInfringedNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	srt_LitigationCaseAxis=mygn_MyriadGeneticsIncSecuritiesLitigationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_LitigationCaseAxis=mygn_RaygenIncVersusMyriadWomensHealthIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LitigationStatusAxis=mygn_SettledLitigationNonContingentPaymentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_LitigationStatusAxis=mygn_SettledLitigationContingentPaymentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	mygn_LitigationInstallmentsAxis=mygn_FirstInstallmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	mygn_LitigationInstallmentsAxis=mygn_SecondInstallmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	mygn_LitigationInstallmentsAxis=mygn_ThirdInstallmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	mygn_LitigationInstallmentsAxis=mygn_FourthInstallmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	mygn_LitigationInstallmentsAxis=mygn_FifthInstallmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

COMMITMENTS AND CONTINGENCIES (Details) $ in Thousands	Oct. 23, 2023 USD ($) installment	Aug. 03, 2023 USD ($)	Dec. 21, 2020 patent	Dec. 31, 2023 USD ($)
Myriad Genetics, Inc. Securities Litigation
Loss Contingencies [Line Items]
Settlement agreement		$ 77,500
Raygen, Inc Versus Myriad Women's Health, Inc.
Loss Contingencies [Line Items]
Number of patents allegedly infringed \| patent			2
Accrual				$ 29,000
Accrual, noncurrent				24,000
Accrual, current				$ 5,000
Raygen, Inc Versus Myriad Women's Health, Inc. \| Settled Litigation, Non-Contingent Payments
Loss Contingencies [Line Items]
Settlement agreement	$ 12,750
Number of annual installments \| installment	3
Raygen, Inc Versus Myriad Women's Health, Inc. \| Settled Litigation, Contingent Payments
Loss Contingencies [Line Items]
Settlement agreement	$ 21,250
Number of annual installments \| installment	5
Raygen, Inc Versus Myriad Women's Health, Inc. \| First Installment \| Settled Litigation, Non-Contingent Payments
Loss Contingencies [Line Items]
Settlement agreement	$ 5,000
Raygen, Inc Versus Myriad Women's Health, Inc. \| First Installment \| Settled Litigation, Contingent Payments
Loss Contingencies [Line Items]
Settlement agreement	5,000
Raygen, Inc Versus Myriad Women's Health, Inc. \| Second Installment \| Settled Litigation, Non-Contingent Payments
Loss Contingencies [Line Items]
Settlement agreement	5,000
Raygen, Inc Versus Myriad Women's Health, Inc. \| Second Installment \| Settled Litigation, Contingent Payments
Loss Contingencies [Line Items]
Settlement agreement	5,000
Raygen, Inc Versus Myriad Women's Health, Inc. \| Third Installment \| Settled Litigation, Non-Contingent Payments
Loss Contingencies [Line Items]
Settlement agreement	2,750
Raygen, Inc Versus Myriad Women's Health, Inc. \| Third Installment \| Settled Litigation, Contingent Payments
Loss Contingencies [Line Items]
Settlement agreement	5,000
Raygen, Inc Versus Myriad Women's Health, Inc. \| Fourth Installment \| Settled Litigation, Contingent Payments
Loss Contingencies [Line Items]
Settlement agreement	5,000
Raygen, Inc Versus Myriad Women's Health, Inc. \| Fifth Installment \| Settled Litigation, Contingent Payments
Loss Contingencies [Line Items]
Settlement agreement	$ 1,250